Glaucoma is the most common ocular disease in Parkinson's

Article

The most frequent ocular complaints in patients suffering from Parkinson's disease (PD) are dry eye syndrome and glaucoma.

According to research published in Klinica Oczna the most frequent ocular complaints in patients suffering from Parkinson's disease (PD) are dry eye syndrome and glaucoma.

The results, compiled by Dr Nowacka et al., Department of Ophthalmology, Pomeranian Medical Academy, Szczecin, Poland, were based on information published in the PubMed library.

Diagnosis of ocular diseases, symptoms and bioelectrical dysfunction of the PD patients was performed using tear film tests, perimetry, optical coherence tomography (OCT) and colour and contrast sensitivity tests, as well as electrophysical recordings such as EOGs, flash pattern and multifocal ERGs and VEPs.

The most frequent ocular diseases within PD patients were determined to be dry eye and glaucoma. Additionally, the most prominent bioelectrical dysfunction was identified in the outer layers of the retina and was found in EOG, PERG and mfERG tests.

As a result, it was found that PD visual deficits could occur without any significant changes in routine examination. Extra attention should be given to the diagnosis and treatment of both glaucoma and dye eye syndrome during the examination of patients with PD.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.